PCDH19 encodes protocadherin 19, a calcium-dependent cell adhesion protein belonging to the δ2 subgroup of non-clustered protocadherins 1. The protein is expressed predominantly in the nervous system with spatiotemporally diverse patterns, particularly in cortical regions during early postnatal development and in the caudate putamen and hippocampal formation of mature brains, suggesting roles in neural circuit formation and maintenance 1. PCDH19 exhibits unique X-linked inheritance patterns where pathogenic variants cause developmental and epileptic encephalopathy 9 (DEE9) in heterozygous females but not in hemizygous males 23. The disorder manifests as childhood-onset epilepsy with brief clusters of febrile and afebrile seizures before age three, cognitive impairment, autistic traits, and behavioral abnormalities 2. The pathogenic mechanism involves cellular interference due to random X chromosome X creating somatic mosaicism, where coexistence of wild-type and variant PCDH19-expressing cells disrupts normal cellular function 34. Additional pathogenic mechanisms include allopregnanolone deficiency, altered steroid gene expression, decreased GABAA receptor function, and blood-brain barrier dysfunction 4. Treatment approaches include clobazam, bromide, and experimental ganaxolone therapy 52.